Search results
Results from the WOW.Com Content Network
An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...
These drugs are used for the treatment of asthma. They may be useful either in the treatment or prevention of asthma attacks. ... Anti-asthmatic agent; B. Beclometasone;
It was not until 1933 when antihistamines, the first type of anti-allergic agents, were developed. [1] Common allergic diseases include allergic rhinitis, allergic asthma and atopic dermatitis with varying symptoms, including runny nose, watery eyes, itchiness, coughing, and shortness of breath. More than one-third of the world's population is ...
This drug prevents the release of inflammatory chemicals such as histamine from mast cells. It is considered a breakthrough drug in management of asthma, as the patients can be freed from steroids in many cases; however, it is mainly effective as a prophylaxis for allergic and exercise-induced asthma, not as a treatment for acute asthma attacks.
[2] [1] Fixed-dose combinations of theophylline and ephedrine were abandoned after the 1970s as they did not allow for dose titration in asthma therapy owing to the toxicity of ephedrine. [ 19 ] The effects of theophylline/ephedrine as a performance-enhancing drug in exercise and sports have been studied.
Monthly Prescribing Reference (MPR) is a widely recognized medical publication that provides comprehensive drug information and prescribing guidelines for healthcare professionals. It is designed to serve as a quick reference guide for physicians, pharmacists, nurse practitioners, and other medical professionals involved in prescribing medications.
Treat an asthma attack by visiting the hospital. Every year, more than 1.6 million Americans wind up in the emergency room because of an asthma attack, according to the CDC.If your attack is so ...
For example, the clinical trial results of omalizumab on asthma have unambiguously settled the long debate on whether IgE plays a central role in the pathogenesis of asthma. [29] Numerous investigator-initiated case studies or small-scale pilot studies of omalizumab have been performed on various allergic diseases and several non-allergic ...